Your browser doesn't support javascript.
loading
Decreased cortical gyrification and surface area in the left medial parietal cortex in patients with treatment-resistant and ultratreatment-resistant schizophrenia.
Kitajima, Kazutoshi; Tamura, Shunsuke; Sasabayashi, Daiki; Nakajima, Shinichiro; Iwata, Yusuke; Ueno, Fumihiko; Takai, Yoshifumi; Takahashi, Junichi; Caravaggio, Fernando; Mar, Wanna; Torres-Carmona, Edgardo; Noda, Yoshihiro; Gerretsen, Philip; Luca, Vincenzo de; Mimura, Masaru; Hirano, Shogo; Nakao, Tomohiro; Onitsuka, Toshiaki; Remington, Gary; Graff-Guerrero, Ariel; Hirano, Yoji.
Afiliação
  • Kitajima K; Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Tamura S; Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Sasabayashi D; Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan.
  • Nakajima S; Research Center for Idling Brain Science, University of Toyama, Toyama, Japan.
  • Iwata Y; Department of Neuropsychiatry, School of Medicine, Keio University, Tokyo, Japan.
  • Ueno F; Research Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada.
  • Takai Y; Research Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada.
  • Takahashi J; Department of Neuropsychiatry, University of Yamanashi Faculty of Medicine, Yamanashi, Japan.
  • Caravaggio F; Research Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada.
  • Mar W; Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Torres-Carmona E; Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Noda Y; Department of Neuropsychiatry, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.
  • Gerretsen P; Research Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada.
  • Luca V; Research Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada.
  • Mimura M; Research Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada.
  • Hirano S; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
  • Nakao T; Department of Neuropsychiatry, School of Medicine, Keio University, Tokyo, Japan.
  • Onitsuka T; Research Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada.
  • Remington G; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
  • Graff-Guerrero A; Research Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada.
  • Hirano Y; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
Psychiatry Clin Neurosci ; 77(1): 2-11, 2023 Jan.
Article em En | MEDLINE | ID: mdl-36165228
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Clozapina Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Psychiatry Clin Neurosci Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Clozapina Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Psychiatry Clin Neurosci Ano de publicação: 2023 Tipo de documento: Article